| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 3 buys and 21 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 | Kewalramani Reshma55 | CEO &President | Buy | 10,000 | $195.65 | $1,956,491.60 | +7.5% | -3.5% | +53.3% | |
| Aug 2, 2021 | Sachs Bruce I51 | Director | Buy | 15,000 | $197.91 | $2,968,650.00 | +57.2% | -6.5% | +38.1% | |
| Jun 2, 2021 | Bhatia Sangeeta N.48 | Director | Sell | 559 | $209.69 | $117,216.13 | -3.4% | -4.8% | +28.4% | |
| May 17, 2021 | Arbuckle Stuart A | EVP, Chief Comm &Ops Officer | Sell | 109 | $216.41 | $23,588.67 | - | -11.7% | +21.0% | |
| May 17, 2021 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 45 | $216.35 | $9,735.87 | - | -11.7% | +21.0% | |
| May 17, 2021 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 112 | $216.34 | $24,230.11 | -0.2% | -11.7% | +21.0% | |
| May 17, 2021 | Altshuler David48 | EVP, Global Research And CSO | Sell | 79 | $216.36 | $17,092.79 | - | -11.7% | +21.0% | |
| May 17, 2021 | Liu Joy | SVP, General Counsel | Sell | 112 | $216.34 | $24,230.11 | -0.7% | -11.7% | +21.0% | |
| May 3, 2021 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 960 | $218.43 | $209,691.03 | -1.4% | -9.0% | +23.5% | |
| Apr 27, 2021 | Sachdev Amit | EVP, Chief Patient Officer | Sale+OE | 3,884 | $216.06 | $839,193.14 | -3.1% | -7.7% | +24.0% |